Effects of Age, Sex and Isometric Exercise on Ventricular-Vascular Interactions During Cardiac Unloading
Launched by TRACY BAYNARD · Apr 14, 2025
Trial Information
Current as of May 15, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how aging and sex affect the communication between the heart and blood vessels when blood pressure drops, a condition known as orthostatic intolerance. As people age, especially women, they may experience dizziness or fainting when standing up because their blood pressure can drop suddenly. The researchers want to see if this communication, or "crosstalk," between the heart and blood vessels becomes worse with age and if hand squeezing can help maintain blood pressure during these situations. Participants will lie down with their legs in a special chamber that simulates low blood pressure, and they will be tested in two different ways: one with just the chamber and another while also squeezing a handgrip.
To be eligible for this study, participants need to be either young adults aged 18-35 or older adults aged 65 and above, and they should be in good health without symptoms of dizziness or fainting. They also need to have normal blood pressure and a healthy weight. Throughout the study, participants will complete two separate testing sessions where they will have their heart function and blood pressure monitored. This research aims to better understand how to prevent issues related to sudden drops in blood pressure, which can be especially dangerous for older adults.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • People aged 18-35 years or aged ≥ 65 years
- • Healthy without symptons of orthostatic intolerance (i.e., nausea, sweating, weakness, visual disturbance)
- • Seated systolic and/or diastolic BP \<140/90 mmHg;
- • Body mass index \<35 kg/m2
- • Recreationally active (≤ 2 days of structured physical activity)
- • Regular menstrual cycles in young females
- Exclusion Criteria:
- • People diagnosed with cardiovascular, diabetes, inflammatory or renal diseases and neurodegenerative-related dementia
- • Tobacco users
- • People prescribed with beta-blockers
- • Pregnant females
- • People unable to fit or get into the lower body negative pressure chamber
About Tracy Baynard
Tracy Baynard is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in managing and overseeing clinical studies, Tracy Baynard focuses on innovative therapeutic areas and strives to ensure the highest standards of compliance, safety, and efficacy. By fostering collaboration among researchers, healthcare professionals, and regulatory bodies, Tracy Baynard aims to expedite the development of groundbreaking treatments while maintaining a patient-centric approach that prioritizes ethical considerations and scientific integrity.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported